The U.N. First Committee deals with disarmament, global challenges and threats to peace that affect the international community. On Nov. 1, it approved a resolution that creates an open-ended working group. The goals of the group are to assess current and future threats to space operations, determine when behavior may be considered irresponsible, “make recommendations on possible norms, rules and principles of responsible behaviors,” and “contribute to the negotiation of legally binding instruments” – including a treaty to prevent “an arms race in space.” We are two space policy experts with specialties in space law and the business of commercial space. We are also the president and vice president at the National Space Society, a nonprofit space advocacy group. It is refreshing to see the U.N. acknowledge the harsh reality that peace in space remains uncomfortably tenuous. This timely resolution has been approved as activities in space become ever more important and – as shown by the Russian test – tensions continue to rise.Current actions in space are governed by the 1967 Outer Space Treaty that was developed within the United Nations, seen here.Basil D Soufi/WikimediaCommons, CC BY-SA
The 1967 Outer Space Treaty
Outer space is far from a lawless vacuum. Activities in space are governed by the 1967 Outer Space Treaty, which is currently ratified by 111 nations. The treaty was negotiated in the shadow of the Cold War when only two nations – the Soviet Union and the U.S. – had spacefaring capabilities. While the Outer Space Treaty offers broad principles to guide the activities of nations, it does not offer detailed “rules of the road.” Essentially, the treaty assures freedom of exploration and use of space to all humankind. There are just two caveats to this, and multiple gaps immediately present themselves. The first caveat states that the Moon and other celestial bodies must be used exclusively for peaceful purposes. It omits the rest of space in this blanket prohibition. The only guidance offered in this respect is found in the treaty’s preamble, which recognizes a “common interest” in the “progress of the exploration and use of space for peaceful purposes.” The second caveat says that those conducting activities in space must do so with “due regard to the corresponding interests of all other States Parties to the Treaty.” A major problem arises from the fact that the treaty does not offer clear definitions for either “peaceful purposes” or “due regard.” While the Outer Space Treaty does specifically prohibit placing nuclear weapons or weapons of mass destruction anywhere in space, it does not prohibit the use of conventional weapons in space or the use of ground-based weapons against assets in space. Finally, it is also unclear if some weapons – like China’s new nuclear capable partial-orbit hypersonic missile – should fall under the treaty’s ban. The vague military limitations built into the treaty leave more than enough room for interpretation to result in conflict.Nonmilitary satellites, like those used to take images for weather forecasts, can also serve important military functions.NASA Goddard Spaceflight Center/Flickr, CC BY
Space is militarized, conflict is possible
Space has been used for military purposes since Germany’s first V2 rocket launch in 1942. Many early satellites, GPS technology, a Soviet Space Station and even NASA’s space shuttle were all either explicitly developed for or have been used for military purposes. With increasing commercialization, the lines between military and civilian uses of space are less blurry. Most people are able to identify terrestrial benefits of satellites like weather forecasts, climate monitoring and internet connectivity but are unaware that they also increase agricultural yields and monitor human rights violations. The rush to develop a new space economy based on activities in and around Earth and the Moon suggests that humanity’s economic dependence on space will only increase. However, satellites that provide terrestrial benefits could or already do serve military functions as well. We are forced to conclude that the lines between military and civilian uses remain sufficiently indistinct to make a potential conflict more likely than not. Growing commercial operations will also provide opportunities for disputes over operational zones to provoke governmental military responses.
Military testing
While there has not yet been any direct military conflict in space, there has been an escalation of efforts by nations to prove their military prowess in and around space. Russia’s test is only the most recent example. In 2007, China tested an anti-satellite weapon and created an enormous debris cloud that is still causing problems. The International Space Station had to dodge a piece from that Chinese test as recently as Nov. 10, 2021. [Understand new developments in science, health and technology, each week.Subscribe to The Conversation’s science newsletter.] Similar demonstrations by the U.S. and India were far less destructive in terms of creating debris, but they were no more welcomed by the international community. The new U.N. resolution is important because it sets in motion the development of new norms, rules and principles of responsible behavior. Properly executed, this could go a long way toward providing the guardrails needed to prevent conflict in space.
From guidelines to enforcement
The U.N. Committee on the Peaceful Uses of Outer Space has been addressing space activities since 1959. However, the remit of the 95-member committee is to promote international cooperation and study legal problems arising from the exploration of outer space. It lacks any ability to enforce the principles and guidelines set forth in the 1967 Outer Space Treaty or even to compel actors into negotiations. The U.N. resolution from November 2021 requires the newly created working group to meet two times a year in both 2022 and 2023. While this pace of activity is glacial compared with the speed of commercial space development, it is a major step in global space policy. Michelle L.D. Hanlon, Professor of Air and Space Law, University of Mississippi and Greg Autry, Clinical Professor of Space Leadership, Policy and Business, Arizona State University This article is republished from The Conversation under a Creative Commons license. Read the original article.
Harkins Theatres Announces Rob Reiner Tribute Screening of The American President
Harkins Theatres has announced a special one-day tribute screening honoring acclaimed filmmaker Rob Reiner, celebrating his life’s work and cinematic legacy.
On December 17, select Harkins locations will screen Reiner’s 1995 political romance The American President, with all proceeds benefiting the Human Rights Campaign. Tickets are priced at $5, making the event both an accessible film experience and a charitable fundraiser.
The tribute was announced via Harkins’ official, verified social media accounts and is positioned as a legacy celebration, not a memorial.
🎥 Why The American President?
Released in 1995 and written by Aaron Sorkin, The American President stars Michael Douglas and Annette Bening and remains one of Rob Reiner’s most politically resonant films. The movie blends romance, idealism, and civic responsibility — themes that have consistently appeared throughout Reiner’s career.
The film later served as a creative blueprint for The West Wing, cementing its place in modern political storytelling.
Rob Reiner’s career spans more than five decades, including landmark films such as:
This Is Spinal Tap
Stand By Me
The Princess Bride
When Harry Met Sally…
Misery
A Few Good Men
His work is often praised for balancing entertainment, empathy, and social conscience, making tribute events like this especially meaningful to longtime audiences.
Hollywood Legend Rob Reiner and Wife Found Dead; Son in Custody
Renowned filmmaker Rob Reiner and his wife, Michele Singer Reiner, were found dead in their Los Angeles home in a reported homicide. Police have arrested their son in connection with the case, and tributes are pouring in.
Director Rob Reiner participates in a discussion following a screening of the film LBJ at the LBJ Presidential Library in Austin, Texas on Saturday October 22, 2016 On Saturday evening October 22, 2016, the LBJ Presidential Library held a sneak peek of Rob Reiner’s new filmÊLBJ, starring Woody Harrelson as the 36th president. The film, which premiered at the Toronto International Film Festival in September, chronicles the life and times of Lyndon Johnson who would inherit the presidency at one of the most fraught moments in American history. Following the screening, director Rob Reiner, actor Woody Harrelson, and writer Joey Hartstone joined LBJ Library Director Mark Updegrove on stage for a conversation about the film. LBJ Library photo by Jay Godwin 10/22/2016
Hollywood Legend Rob Reiner and Wife Found Dead; Son in Custody
December 15, 2025
Renowned filmmaker and actor Rob Reiner, 78, and his wife Michele Singer Reiner, 68, were found dead in their Brentwood, Los Angeles home on Sunday, authorities say. Emergency responders were called to the residence Sunday afternoon, where both were discovered with fatal wounds consistent with a stabbing. Police are treating the case as a double homicide.
Los Angeles police arrested the couple’s 32-year-old son, Nick Reiner, in connection with the deaths. He is being held in custody as investigators continue to piece together the circumstances surrounding the incident.
2016 SAMHSA Voice Awards
Reiner was one of Hollywood’s most influential figures, known for his work as a director, producer and actor. His career spanned decades, from early television fame to directing beloved films that shaped American cinema.
Friends, colleagues and public figures have begun sharing tributes and reactions to the news as the investigation is ongoing.
More details will be updated as they become available.
FDA’s COVID-19 Vaccine Safety Claims Lack Solid Evidence—Why Overreaction Could Harm Public Health
COVID-19 vaccine safety: The FDA’s claims about COVID-19 vaccine deaths in children lack strong evidence and could restrict vaccine access. Learn why experts say VAERS reports aren’t proof, and how overreacting may harm public health and trust in vaccines.
The death of children due to an unsafe vaccine is a serious allegation. I am a pediatric cardiologist who has studied the link between COVID-19 vaccines and heart-related side effects such as myocarditis in children. To my knowledge, studies to date have shown such side effects are rare, and severe outcomes even more so. However, I am open to new evidence that could change my mind. But without sufficient justification and solid evidence, restricting access to an approved vaccine and changing well-established procedures for testing vaccines would carry serious consequences. These moves would limit access for patients, create roadblocks for companies and worsen distrust in vaccines and public health. In my view, it’s important for people reading about these FDA actions to understand how the evidence on a vaccine’s safety is generally assessed.
Determining cause of death
The FDA memo claims that the deaths of these children were directly related to receiving a COVID-19 immunization. From my perspective as a clinician, it is awful that any child should die from a routine vaccination. However, health professionals like me owe it to the public to uphold the highest possible standards in investigating why these deaths occurred. If the FDA has evidence demonstrating something that national health agencies worldwide have missed – widespread child deaths due to myocarditis caused by the COVID-19 vaccine – I don’t doubt that even the most pro-vaccine physician will listen. So far, however, no such evidence has been presented. While a death logged in VAERS is a starting point, on its own it is insufficient to conclude whether a vaccine caused the death or other medical causes were to blame. To demonstrate a causal link, FDA staff and physicians must align the VAERS report with physicians’ assessments of the patient, as well as data from other sources for monitoring vaccine safety. These include PRISM, which logs insurance claims data, and the Vaccine Safety Datalink, which tracks safety signals in electronic medical records. It’s known that most deaths logged only in VAERS of children who recently received vaccines have been incorrectly attributed to the vaccines – either by accident or in some cases on purpose by anti-vaccine activists.
Heart-related side effects of COVID-19 vaccines
In his Substack and Twitter accounts, Prasad has said that he believes the rate of severe cardiac side effects after COVID-19 vaccination is severely underestimated and that the vaccines should be restricted far more than they currently are. In a July 2025 presentation, Prasad quoted a risk of 27 cases per million of myocarditis in young men who received the COVID-19 vaccine. A 2024 review suggested that number was a bit lower – about 20 cases out of 1 million people. But that same study found that unvaccinated people had greater risk of heart problems after a COVID-19 infection than vaccinated people. In a different study, people who got myocarditis after a COVID-19 vaccination developed fewer complications than people who got myocarditis after a COVID-19 infection. Existing vaccine safety infrastructure in the U.S. successfully identifies dangers posed by vaccines – and did so during the COVID-19 pandemic. Today, most COVID-19 vaccines in the U.S. rely on mRNA technology. But as vaccines were first emerging during the COVID-19 pandemic, two pharmaceutical companies, Janssen and AstraZeneca, rolled out a vaccine that used a different technology, called a viral vector. This type of vaccine had a very rare but genuine safety problem that was detected.A report in VAERS is at most a first step to determining whether a vaccine caused harm. VAERS, the Vaccine Safety Datalink, clinical investigators in the U.S. and their European counterparts detected that these vaccines did turn out to cause blood clotting. In April 2021, the FDA formally recommended pausing their use, and they were later pulled from the market. Death due to myocarditis from COVID-19 vaccination is exceedingly rare. Demonstrating that it occurred requires proof that the person had myocarditis, evidence that no other reasonable cause of death was present, and the absence of any additional cause of myocarditis. These factors cannot be determined from VAERS data, however – and to date, the FDA has presented no other relevant data.
A problematic vision for future vaccine approvals
Currently, vaccines are tested both by seeing how well they prevent disease and by how well they generate antibodies, which are the molecules that help your body fight viruses and bacteria. Some vaccines, such as the COVID-19 vaccine and the influenza vaccine, need to be updated based on new strains. The FDA generally approves these updates based on how well the new versions generate antibodies. Since the previous generation of vaccines was already shown to prevent infection, if the new version can generate antibodies like the previous one, researchers assume its ability to prevent infection is comparable too. Later studies can then test how well the vaccines prevent severe disease and hospitalization. The FDA memo says this approach is insufficient and instead argues for replacing such studies with many more placebo-controlled trials – not just for COVID-19 vaccines but also for widely used influenza and pneumonia vaccines. That may seem reasonable theoretically. In practice, however, it is not realistic. Today’s influenza vaccines must be changed every season to reflect mutations to the virus. If the FDA were to require new placebo-controlled trials every year, the vaccine being tested would become obsolete by the time it is approved. This would be a massive waste of time and resources.Influenza vaccines must be updated for every flu season.Jacob Wackerhausen/iStock via Getty Images Plus Also, detecting vaccine-related myocarditis at the low rate at which it occurs would have required clinical trials many times larger than the ones that were done to approve COVID-19 mRNA vaccines. This would have cost at least millions of dollars more, and the delay in rolling out vaccines would have also cost lives. Placebo-controlled trials would require comparing people who receive the updated vaccine with people who remain unvaccinated. When an older version of the vaccine is already available, this means purposefully asking people to forgo that vaccine and risk infection for the sake of the trial, a practice that is widely considered unethical. Current scientific practice is that only a brand-new vaccine may be compared against placebo. While suspected vaccine deaths should absolutely be investigated, stopping a vaccine for insufficient reasons can lead to a significant drop in public confidence. That’s why it’s essential to thoroughly and transparently investigate any claims that a vaccine causes harm.
